Savient Accused of Insolvency by Tang Capital in Lawsuit

Savient Pharmaceuticals Inc. was sued by creditor Tang Capital Partners, an investment fund focusing on the life sciences that contended the drugmaker is insolvent and asked a judge to appoint a receiver.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.